Prevention & Chronic Conditions

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

Drug Interactions in Pulmonary Arterial Hypertension and Their Implications

Citation:

US Cardiology 2009;6(2):101–6

Baroreflex Activation in Drug-resistant Hypertension

Citation:

US Cardiology 2009;6(1):29–32

Cardiac Rehabilitation Update 2008 - Biological, Psychological, and Clinical Benefits

Citation:

US Cardiology 2008;5(1):72–6

A Review of the Antihypertensive and Renal-protective Effects of Irbesartan

Citation:

US Cardiology 2010;7(2):25–33